title: Trial of amifostine in autologous stem cell transplant.
authors.forename: P
authors.initials: P
authors.lastname: Sastry
authors.forename: R
authors.initials: R
authors.lastname: Bhagwat
authors.forename: G
authors.initials: G
authors.lastname: Biswas
authors.forename: A
authors.initials: A
authors.lastname: Khadwal
authors.forename: P
authors.initials: P
authors.lastname: Narayanan
authors.forename: A
authors.initials: A
authors.lastname: Bakshi
authors.forename: P
authors.initials: P
authors.lastname: Parikh
mesh_terms: D000293:Adolescent; D000328:Adult; D004999:Amifostine / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D002330:Carmustine / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D006689:Hodgkin Disease / Q000097:blood / Q000150:complications / Q000628:therapy*; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications / Q000628:therapy*; D011034:Podophyllotoxin / Q000008:administration & dosage / Q000009:adverse effects; D011837:Radiation-Protective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous
chemical_list: D011837:Radiation-Protective Agents; D003561:Cytarabine; D011034:Podophyllotoxin; D004999:Amifostine; D008558:Melphalan; D002330:Carmustine